Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Drugs of Today (Barcelona, Spain : 1998)|August 8, 2014
Ceritinib for the treatment of non-small cell lung cancerL Landi, F CappuzzoAnnals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2016
Crizotinib: from discovery to accelerated development to front-line treatmentF Blackhall, F CappuzzoAnnali Italiani Di Chirurgia|November 1, 1996
[Colorectal carcinoma: therapeutic approach in patients already treated with metastasis resection]E Bajetta, F CappuzzoAnti-Cancer Drugs|September 15, 2001
[Role of gemcitabine in the treatment of advanced non-small cell lung cancer: review of the main phase II and phase III trials]L Crino, F CappuzzoOncogene|August 15, 2009
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancerF R Hirsch, M Varella-Garcia, F CappuzzoBritish Journal of Cancer|July 17, 2003
ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four casesF Cappuzzo, C Calandri, S Bartolini, et al.Future Oncology (London, England)|March 25, 2006
Role of gemcitabine in cancer therapyL Toschi, G Finocchiaro, S Bartolini, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Development of gemcitabine in non-small cell lung cancer: the Italian contributionG Metro, F Cappuzzo, G Finocchiaro, et al.The International Journal of Biological Markers|February 17, 2017
Surrogate predictive biomarkers for response to anti-EGFR agents: state of the art and challengesF Cappuzzo, L Toschi, G Finocchiaro, et al.The International Journal of Biological Markers|May 24, 2007
Surrogate predictive biomarkers for response to anti-EGFR agents: state of the art and challengesF Cappuzzo, L Toschi, G Finocchiaro, et al.Pageof 6